- Home
- MURA vs OPHC Comparison
MURA vs OPHC Comparison
Compare MURA & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- OPHC
- Stock Information
- Founded
- MURA 2013
- OPHC 2000
- Country
- MURA Ireland
- OPHC United States
- Employees
- MURA N/A
- OPHC N/A
- Industry
- MURA
- OPHC Major Banks
- Sector
- MURA
- OPHC Finance
- Exchange
- MURA Nasdaq
- OPHC Nasdaq
- Market Cap
- MURA 45.8M
- OPHC 51.8M
- IPO Year
- MURA N/A
- OPHC N/A
- Fundamental
- Price
- MURA $2.42
- OPHC $4.61
- Analyst Decision
- MURA Strong Buy
- OPHC
- Analyst Count
- MURA 3
- OPHC 0
- Target Price
- MURA $12.00
- OPHC N/A
- AVG Volume (30 Days)
- MURA 79.3K
- OPHC 10.8K
- Earning Date
- MURA 08-12-2025
- OPHC 08-05-2025
- Dividend Yield
- MURA N/A
- OPHC N/A
- EPS Growth
- MURA N/A
- OPHC 30.24
- EPS
- MURA N/A
- OPHC 1.33
- Revenue
- MURA N/A
- OPHC $39,980,000.00
- Revenue This Year
- MURA N/A
- OPHC N/A
- Revenue Next Year
- MURA N/A
- OPHC N/A
- P/E Ratio
- MURA N/A
- OPHC $3.46
- Revenue Growth
- MURA N/A
- OPHC 53.28
- 52 Week Low
- MURA $0.95
- OPHC $3.53
- 52 Week High
- MURA $4.74
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- MURA 42.86
- OPHC 57.98
- Support Level
- MURA $2.42
- OPHC $4.53
- Resistance Level
- MURA $2.54
- OPHC $4.70
- Average True Range (ATR)
- MURA 0.09
- OPHC 0.06
- MACD
- MURA -0.00
- OPHC 0.01
- Stochastic Oscillator
- MURA 1.58
- OPHC 54.76
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.